Esteban Ribera
Department of Infectious Diseases
Hospital Universitari Vall d'Hebron
Barcelona
Spain
Name/email consistency: high
- Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study). Ribera, E., Paradiñeiro, J.C., Curran, A., Sauleda, S., García-Arumí, E., Castella, E., Puiggròs, C., Crespo, M., Feijoo, M., Diaz, M., Del Saz, S.V., Planas, M., Sureda, D., Falcó, V., Ocaña, I., Pahissa, A. HIV. Clin. Trials (2008)
- Double-boosted protease inhibitor antiretroviral regimens: what role? Ribera, E., Curran, A. Drugs (2008)
- Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis. Ribera, E., Azuaje, C., Lopez, R.M., Domingo, P., Curran, A., Feijoo, M., Pou, L., Sánchez, P., Sambeat, M.A., Colomer, J., Lopez-Colomes, J.L., Crespo, M., Falcó, V., Ocaña, I., Pahissa, A. J. Antimicrob. Chemother. (2007)
- Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen. Ribera, E., Azuaje, C., Lopez, R.M., Diaz, M., Feijoo, M., Pou, L., Crespo, M., Curran, A., Ocaña, I., Pahissa, A. AIDS (2006)
- Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients. Ribera, E., Rodríguez-Pardo, D., Rubio, M., Soler, A., Pedrol, E., Blanco, J.L., González, A., Crespo, M., Falcó, V., Ocaña, I., Deig, E., Miró, J.M., Pahissa, A. Antivir. Ther. (Lond.) (2005)
- Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study). Ribera, E., Azuaje, C., Lopez, R.M., Domingo, P., Soriano, A., Pou, L., Sánchez, P., Mallolas, J., Sambea, M.A., Falco, V., Ocaña, I., Lopez-Colomes, J.L., Gatell, J.M., Pahissa, A. J. Acquir. Immune Defic. Syndr. (2005)
- Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults. Ribera, E., Lopez, R.M., Diaz, M., Pou, L., Ruiz, L., Falcó, V., Crespo, M., Azuaje, C., Ruiz, I., Ocaña, I., Clotet, B., Pahissa, A. Antimicrob. Agents Chemother. (2004)
